Author: Kate Park

Intero Biosystems is offering pharmaceutical companies laboratory-grown human intestines as an alternative to animal testing. The startup aims to scale its production capacity and further develop its organoid technology to meet the rising demand from regulators.

Mosqitter is upgrading its mosquito-trapping devices to function as an artificial intelligence surveillance network. The system aims to identify insect species, track population levels, and deliver earlier alerts regarding potential health threats from mosquito-borne illnesses.